Patent details

Basic Information

Publication number:

EP2173737

PCT Application Number:

PCT/US/2008/070103

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP087818688

PCT Publication Number:

WO/2009/012277

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHOD FOR MODULATING GPR119 G PROTEIN-COUPLED RECEPTOR AND SELECTED COMPOUNDS

French Title of Invention:

PROCÉDÉ DE MODULATION DE RÉCEPTEUR GPR119 DE LA PROTÉINE G ET COMPOSÉS SÉLECTIONNÉS

German Title of Invention:

VERFAHREN ZUR MODULATION DES GPR119-G-PROTEINGEKOPPELTEN REZEPTORS UND AUSGEWÄHLTE VERBINDUNGEN

SPC Number:

Dates

Filing date:

16/07/2008

Grant date:

11/01/2012

EP Publication Date:

11/01/2012

PCT Publication Date:

22/01/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/04/2010

EP B1 Publication Date:

11/01/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/07/2014

Expiration date:

16/07/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/07/2008

 

 

Name:

Bristol-Myers Squibb Company

Address:

Route 206 and Province Line Road P.O. Box 4000, Princeton NJ 08543-4000, United States (US)

Agent

Name:

MARKS & CLERK LLP

From:

28/03/2012

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

WANG Ying

Address:

United States (US)

2

Name:

ROSSI Karen A.

Address:

United States (US)

3

Name:

WACKER Dean A.

Address:

United States (US)

Priority

Priority Number:

950162 P

Priority Date:

17/07/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 401/12;

Filing date	Document type	Number of pages
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56